Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FC9U1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,603
Award facts
- Contract value 100% obligated
- $13,603.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at approximately $13.6K, represents a non-competitive set-aside procurement and is scheduled for completion by June 20, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $1 billion and extends through December 2026, positioning the company as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
AmerisourceBergen Drug Corp serves as a major pharmaceutical and healthcare solutions provider supporting the Defense Logistics Agency's Medical Supply Chain with a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contracting history demonstrates consistent capability in fulfilling competitively awarded delivery orders with firm fixed pricing, ranging from small-value transactions to orders exceeding $45K. As a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen supports Defense Health Agency operations and other federal healthcare systems, serving as a critical link in the global pharmaceutical supply chain for military medicine and veteran care initiatives.
Quick answers
Who was awarded contract SPE2DB25FC9U1?
SPE2DB25FC9U1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FC9U1 worth?
The government has obligated $13,603 on SPE2DB25FC9U1.
Is contract SPE2DB25FC9U1 an order under another contract?
Yes. SPE2DB25FC9U1 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC9U1 competed?
The extent of competition for SPE2DB25FC9U1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award